Although I respect Patrick's vision, Positron's execution of its business plan has been less than impressive. I am speculating ... but I still believe that Patrick's reputation was severely damaged by the SEC investigation, and this has caused Positron's business partners/customers to distance themselves. Patrick may have been forced out by the Board of Directors. At this point, new leadership will be a positive for this company. We all know the growth rate projections of the nuclear medicine market ... Why has Positron still not sold any Sr-82? Is Positron's entire future reliant on one customer (Jubilant)?
News 
Market Data 
Discover 
AI
